总时间（秒）：12.86
问答时间（秒）：10.68

Based on the provided literature, I will extract and standardize the required information according to the predefined JSON framework.

**Variants Include**

*   Gene: DJ-1
*   Variants:
    *   HGVS: NM_007334.4:c.77T>G (Standardized via API)
        +   cDNA Change:
            -   Transcript: NM_007334.4
            -   Ref: T
            -   Alt: G
            -   Position: 77
        +   Protein Change:
            -   Ref: L
            -   Alt: V
            -   Position: 26
        +   Description in input context: c.77T>G (p.L26V)
    *   HGVS: NM_007334.4:c.106C>A (Standardized via API)
        +   cDNA Change:
            -   Transcript: NM_007334.4
            -   Ref: C
            -   Alt: A
            -   Position: 106
        +   Protein Change:
            -   Ref: S
            -   Alt: N
            -   Position: 36
        +   Description in input context: c.106C>A (p.S36N)
    *   HGVS: NM_007334.4:c.77T>G, Cys106DD (Standardized via API)
        +   cDNA Change:
            -   Transcript: NM_007334.4
            -   Ref: T
            -   Alt: G
            -   Position: 77
        +   Protein Change:
            -   Ref: L
            -   Alt: V
            -   Position: 26
        +   Description in input context: c.77T>G (p.L26V)

**Described Disease**

*   Described Disease: Parkinson disease (PD)
*   MONDO: N.D.

**Experiment Method**

*   Assay Method: Western Blot, Suppression of apoptosis signal-regulating kinase 1 (ASK1) activity
*   Material used:
    +   Material Source: Cell line (knockout mouse embryonic fibroblasts)
    +   Material Name: DJ-1 deficient cells
    +   Description: The experiment was conducted using knockout mouse embryonic fibroblasts deficient in DJ-1.
*   Readout type: Quantitative
*   Readout description:
    *   Variant: NM_007334.4:c.77T>G (p.L26V)
        -   Conclusion: Abnormal
        -   Molecular Effect: partial loss-of-function
        -   Result Description: The variant c.77T>G in DJ-1 reduced ASK1 activity.
*   Biological replicates:
    +   Biological replicates: Yes
    +   Description: Three biological replicates were performed.
*   Technical replicates:
    +   Technical replicates: Yes
    +   Description: Each sample was run in triplicate.
*   Basic positive control:
    +   Basic positive control: N.D.
    +   Description: N.D.
*   Basic negative control:
    +   Basic negative control: N.D.
    +   Description: N.D.
*   Validation controls P/LP:
    +   Validation controls P/LP: Yes
    +   Counts: 2
*   Validation controls B/LB:
    +   Validation controls B/LB: Yes
    +   Counts: 1
*   Statistical analysis method:
    +   Statistical analysis method: N.D.
*   Threshold for normal readout:
    +   Threshold for normal readout: N.D.
    +   Source: Literature
*   Threshold for abnormal readout:
    +   Threshold for abnormal readout: N.D.
    +   Source: Literature
*   Approved assay:
    +   Approved assay: No

Please note that the "Approved assay" field was marked as "No" because the experimental protocol used in the literature is not generally accepted or recommended for studying Parkinson disease.